Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Medulloblastoma
WNT, SHH, Group 3 and Group 4 disease, and relapse after craniospinal radiotherapy.
ASCO Annual Meeting 2026
29 May – 2 Jun 2026, Chicago · Journal of Clinical Oncology 44 (16_suppl; LBAs in 17_suppl)
All 7,222 regular abstracts and 60 late-breaking abstracts have JCO supplement DOIs in Crossref.
Indexed in Crossref
5 abstracts matching medulloblastoma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 11:14 UTC. This is a keyword search, not the complete abstract book.
- E14106Exploiting ribosomal biogenesis dependence through RNA polymerase I inhibition in medulloblastoma.Shahad Mohammed Abdulsahib, Prabhakar Venkata, Manjeet Rao
- E14112Cellular consequences of a germline SMC5 variant enriched in medulloblastoma.Khadija Jadun, Zhudi Pan, Brian McCue, Richa Sharma
- E22005Post-operative neurologic outcomes in children with WNT-medulloblastoma.Daniel Bishay, Jennifer Cotter, Therry Malone, Mark Krieger et al.
- 2087Efficacy of high-dose chemotherapy in adult patients with relapsed or refractory medulloblastoma.Nurlan Mammadzada, Berkan Karadurmus, Esmanur Kaplan Tuzun, Hüseyin Atacan et al.
- E14104Adult medulloblastoma: Long-term follow-up analysis of a single-center cohort.Luis Fernando Suárez Justiniano, Ana Flávia De Seixas Salomão, Douglas Tozzo Machado Ferreira, Alice Nayane Rosa Morais et al.